No Increased Fracture Risk With Canagliflozin in Type 2 Diabetes
Rate of the primary outcome was similar for canagliflozin, glucagon-like peptide-1 agonist
Price of Alirocumab Would Have to Be Cut to Be Cost-Effective
Price of alirocumab would have to decrease from original cost of $14,560 to $1,974 to be cost-effective
One in 10 EMS Encounters for Involuntary Psychiatric Holds
Alameda County study shows 41 percent directly transported to standalone psych emergency services
Proportion of Cancers Due to Excess Body Weight Varies by State
Population-attributable fraction varied from 3.9 percent in Montana to 6.0 percent in Texas for men
College Students at Increased Risk for SgB Meningococcal Dz
Students, parents, health care providers should be aware of the availability of MenB vaccines
Impaired Cognitive Status Impacts Rehab Potential in SNFs
Older adults with cognitive impairment admitted to skilled nursing facilities make fewer gains
Kidney Stones Tied to Increased Renal Cell Carcinoma Risk
Risk increased for papillary RCC but not clear-cell RCC; risk for upper tract urothelial carcinoma increased
December 2018 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for December 2018. This roundup includes the latest...
December 2018 Briefing – Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for December 2018. This roundup includes the...
December 2018 Briefing – Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for December 2018. This roundup includes the latest...
